Advertisement

Topics

Vascepa® (Icosapent Ethyl) Showed Reductions in Potentially Atherogenic Lipid and Inflammatory ...

11:30 EST 13 Nov 2017 | BioMedReports - Blog

BEDMINSTER, N.J. and DUBLIN, Ireland, Nov. 13, 2017 (GLOBE NEWSWIRE)

Read more...

Original Article: Vascepa® (Icosapent Ethyl) Showed Reductions in Potentially Atherogenic Lipid and Inflammatory ...

NEXT ARTICLE

More From BioPortfolio on "Vascepa® (Icosapent Ethyl) Showed Reductions in Potentially Atherogenic Lipid and Inflammatory ..."

Advertisement
Quick Search
Advertisement
Advertisement